Biocept Competitors and Similar CompaniesClear all
Biocept's competitors and similar companies include Castle Biosciences, Evox Therapeutics, Epic Sciences and Apostle.
 Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. |  Castle Biosciences Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers. |  Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. |  Epic Sciences Epic Sciences is a company developing diagnostics to personalize the treatment and management of cancer. |  Apostle Apostle is a biotechnology company engaged in research, development, and licensing of products and services for diagnosis and treatment of human diseases. | |
Founding Date | Founding Date 1993 | Founding Date 2008 | Founding Date 2016 | Founding Date 2008 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary | Type Private | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Friendswood, US HQ Phoenix, US | Locations Oxford, GB HQ | Locations San Diego, US HQ | Locations Menlo Park, US HQ San Jose, US |
Employees | Employees 878% decrease | Employees 61013% increase | Employees 452% decrease | Employees 4711% decrease | Employees 22 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 936.9 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $344.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $28.4m (FY, 2022) | Cost of goods $71m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ($2.5m) (FY, 2022) | Gross profit $273.2m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($32.1m) (FY, 2022) | Net income ($24.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 12 (Q1, 2022) | Patents (US) N/A | Patents (US) 5 (Sep, 2022) | Patents (US) N/A |
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) 13 (FY, 2021) | Trademarks (US) N/A | Trademarks (US) 3 (Sep, 2022) | Trademarks (US) N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 52m (over 7 years ago) | Latest funding round $ 3.3m (about 7 years ago) |
Total funding raised | Total funding raised $ 15.9m | Total funding raised $ 46.5m | Total funding raised $ 158.6m | Total funding raised $ 152.5m | Total funding raised $ 5.7m |
For sources of this data, please see the company profile
View Company Profiles
Castle Biosciences
HQ
Friendswood, US
Employees
610↑ 13% increase
Castle Biosciences is a company developing and commercializing diagnostic and prognostic tests for dermatologic cancers.
View companyEvox Therapeutics
HQ
Oxford, GB
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
View companyEpic Sciences
HQ
San Diego, US
Employees
47↓ 11% decrease
Epic Sciences is a company developing diagnostics to personalize the treatment and management of cancer.
View companyApostle
HQ
Menlo Park, US
Employees
22
Apostle is a biotechnology company engaged in research, development, and licensing of products and services for diagnosis and treatment of human diseases.
View company